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of lck–racK1–actinin-1 Multiprotein 
network affecting lck redistribution
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Pavel Rˇehulka2, Jirˇí Stulík2 and Dominik Filipp1*
1 Laboratory of Immunobiology, Institute of Molecular Genetics AS CR, Prague, Czech Republic, 2 Faculty of Military Health 
Sciences, Institute of Molecular Pathology, Hradec Králové, Czech Republic
The initiation of T-cell signaling is critically dependent on the function of the member 
of Src family tyrosine kinases, Lck. Upon T-cell antigen receptor (TCR) triggering, Lck 
kinase activity induces the nucleation of signal-transducing hubs that regulate the 
formation of complex signaling network and cytoskeletal rearrangement. In addition, 
the delivery of Lck function requires rapid and targeted membrane redistribution, but 
the mechanism underpinning this process is largely unknown. To gain insight into this 
process, we considered previously described proteins that could assist in this process 
via their capacity to interact with kinases and regulate their intracellular translocations. 
An adaptor protein, receptor for activated C kinase 1 (RACK1), was chosen as a viable 
option, and its capacity to bind Lck and aid the process of activation-induced redistri-
bution of Lck was assessed. Our microscopic observation showed that T-cell activation 
induces a rapid, concomitant, and transient co-redistribution of Lck and RACK1 into 
the forming immunological synapse. Consistent with this observation, the formation 
of transient RACK1–Lck complexes were detectable in primary CD4+ T-cells with their 
maximum levels peaking 10 s after TCR–CD4 co-aggregation. Moreover, RACK1 prefer-
entially binds to a pool of kinase active pY394Lck, which co-purifies with high molecular 
weight cellular fractions. The formation of RACK1–Lck complexes depends on functional 
SH2 and SH3 domains of Lck and includes several other signaling and cytoskeletal 
elements that transiently bind the complex. Notably, the F-actin-crosslinking protein, 
α-actinin-1, binds to RACK1 only in the presence of kinase active Lck suggesting that 
the formation of RACK1–pY394Lck–α-actinin-1 complex serves as a signal module cou-
pling actin cytoskeleton bundling with productive TCR/CD4 triggering. In addition, the 
treatment of CD4+ T-cells with nocodazole, which disrupts the microtubular network, 
also blocked the formation of RACK1–Lck complexes. Importantly, activation-induced 
Lck redistribution was diminished in primary CD4+ T-cells by an adenoviral-mediated 
knockdown of RACK1. These results demonstrate that in T cells, RACK1, as an essential 
component of the multiprotein complex which upon TCR engagement, links the binding 
of kinase active Lck to elements of the cytoskeletal network and affects the subcellular 
redistribution of Lck.
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inTrODUcTiOn
Signaling through the T-cell antigen receptor (TCR) has the 
potential to trigger a broad range of cellular responses (1). During 
TCR triggering, two Src family tyrosine kinases (SFKs) – Lck and 
Fyn – provide critical enzymatic and structural functions that 
predicate the generation of the most proximal signals emanating 
from the TCR (2). In CD4+ resting T-cells, Lck is targeted to 
the inner leaflet of the plasma membrane via its NH2-terminal 
myristate/palmitate motif. A considerable portion of this 
membrane-associated Lck has been shown to be non-covalently 
attached to the TCR co-receptor, CD4 (3). Lck kinase activity is 
positively and negatively regulated by the phosphorylation of 
two tyrosine residues, Y394 and Y505, respectively, the former 
being associated with fully active Lck (4). Upon TCR binding 
to a cognate peptide which is recognized in the context of 
MHCII, CD4 interacts with the non-variable region of the same 
MHCII and juxtaposes its bound kinase active Lck within the 
vicinity of immunoreceptor tyrosine-based activation motifs 
(ITAMs) of the CD3 chains of TCR. Lck then phosphorylates 
ITAMs that serve as docking sites for activated tyrosine kinase 
ZAP-70, which in turn proceeds to phosphorylate the adaptor 
protein LAT at multiple sites. This leads to the recruitment of 
downstream signaling elements such as phospholipase C-γ1 
and adaptor proteins Grb2 and GADS which trigger complex 
signaling cascades, Ca2+ flux, cytoskeletal reorganization, and 
integrin activation (5, 6).
There is a general consensus that a T-cell membrane structural 
network provides the necessary milieu for coordination and 
integration of processes that regulate the onset of T-cell signal-
ing. Several types of membrane heterogeneities that concentrate 
specific and distinct sets of signaling molecules have been 
proposed. These account for, but are not limited to, lipid rafts 
(LRs), nanoclusters, protein islands, pickets and fences, transient 
confinement zones, microclusters, immunological synapse (IS), 
and supramolecular activation cluster (SMAC) (7). LRs, which 
represent a sizable fraction of the plasma membrane, are in terms 
of their composition, structure, and function among the most 
studied (8, 9). Due to their enrichment in cholesterol and sphin-
golipids, LRs exist in a liquid-ordered phase, hence are largely 
resistant to solubilization by mild non-ionic detergents, and can 
be isolated as detergent-resistant membrane (DRM) fractions. 
While DRMs are not equated with native LRs, their content and 
properties allow the examination of changes in membrane raft 
content induced by TCR signaling (10–13).
The compartmentalization of membrane-residing signaling 
proteins into LRs provides the basis for their physical segrega-
tion and transient clustering (14). Two distinct types of DRM 
fractions have been documented in resting T-cells: light and 
heavy DRMs, which are enriched for non-overlapping subsets of 
signaling molecules (15). Importantly, TCR activation-induced 
LR redistribution of Lck and several other signaling molecules 
which are involved in the initiation of signaling cascades, such as 
CD3ζ, LAT, and CD45, have been documented (14).
While TCR triggering is enzymatically initiated by Lck-
mediated tyrosine phosphorylation of CD3 ITAMs, Lck does 
not remain in a stationary position. There are several lines of 
evidence that demonstrate that the delivery of Lck function is 
accompanied by its rapid and targeted membrane redistribu-
tion. Notably, we previously reported that LR plays an essential 
role in temporal and spatial coordination and activation-
dependent redistribution of Lck and Fyn kinases (16, 17). 
A proposed Lck-dependent Fyn activation model posits that 
antibody-mediated TCR–CD4 co-aggregation-induced Lck 
activation outside LR results in Lck translocation to light LR 
where the activation of LR-resident Fyn ensues. Similarly, the 
“Lck standby model” which does not specifically account for 
the existence of LR, proposes that upon TCR triggering, the 
constitutively kinase active fraction of membrane-bound Lck 
is targeted to areas where it colocalizes with ITAMs of TCR/
CD3 complex (18). Studies by Rossy et al. also demonstrated 
the impact of TCR stimulation on Lck distribution, which 
was dependent on active conformation of the kinase (19). 
Furthermore, it has been reported that the early redistribution 
of Lck to the forming IS with its maximum kinase activity 
occurs between 2 and 5  min after initiation of T-cell–APC 
conjugation (20). While these data collectively established Lck 
as a mobile signaling element that is indispensable for proximal 
T-cell signaling (21), the underlying process regulating its 
redistribution is currently unknown. The main aim of the 
study was to gain insight into the molecular mechanism and 
its functional elements that regulate the early recruitment of 
Lck to LR and the formation of the IS.
To consider proteins that could act in aiding the process 
of activation-induced redistribution of Lck, we searched for 
previously described molecules with the following attributes: 
(i) regulation of intracellular translocation of kinases, (ii) ability 
to interact with SFKs and modulate their kinase activity, (iii) 
capacity to associate with elements of the cytoskeletal network, 
and (iv) capacity to interact with multiple partners. Among 
several candidates, receptor for activated C kinase 1 (RACK1) 
turned out to be a viable option. RACK1 is a 36-kDa scaffolding 
protein, which is evolutionary highly conserved in a wide range 
of eukaryotes including members of the plant, fungi, and yeast 
kingdoms (22). It is expressed in all mammalian cells, and its 
deficiency is embryonically lethal (23). It contains seven WD40 
repeats (24) with a propeller structure, which provides RACK1 
with multiple binding sites allowing interaction with a large 
number of functionally and structurally distinct proteins such as 
G proteins, kinases, phosphatases, and IP3 receptors (25). This 
interactivity predisposes RACK1 to be involved in a broad range 
of cellular processes, from signal transduction, transcription, 
translation, viral infection, cell migration, development, and 
epigenetics to cancer (25). Its interactions with protein kinase 
C (PKC) (26), membrane-bound receptors such as integrin β 
(27, 28), NMDA receptor (29), FAK, PDE, and SFKs such as 
Src and Fyn (30–32) have been studied in detail. Importantly, 
it has been shown that RACK1 can positively or negatively 
modulate the kinase activity of SFK Src, Fyn, and Lck, with the 
resulting effect being cell context specific (27–33). However, the 
specific role of RACK1 in proximal T-cell signaling has not been 
investigated so far.
An important and yet enigmatic function of RACK1 is the 
coordinated translocation and redistribution of its activated 
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binding partners to a distinct subcellular compartment (25). 
While mechanisms regulating these dynamic processes are still 
obscure, the multiple protein-binding capacity of RACK1’s seven 
WD40 domains and its association with beta-spectrin and/or 
plectin which mediate interactions with major cytoskeletal ele-
ments, actin, intermediate filaments, and possibly microtubules 
most likely contribute to these processes (34, 35). Interestingly, 
RACK1 is also a constituent of the ribosomal assembly where 
it recruits signaling components that enable the regulation of 
translation (36, 37).
Here, we report microscopic, biochemical, and genetic data 
characterizing RACK1 as an integral part of signaling transduc-
tion network capable of transiently co-binding the activated 
Lck and elements of cytoskeleton, thus revealing its potential in 
aiding Lck redistribution by integrating TCR/CD4–Lck signals 
with filament networks.
MaTerials anD MeThODs
Mice
Three mice strains, 6–8  weeks old, were used: wild-type (WT) 
C57BL/6, OTII transgenic mice with transgenic (tg) TCRα/TCRβ 
receptor specific for OVA peptide (38), and double tg DO11.10 
TCR/tg CARΔ (TgCAR) (Taconic), which express human 
coxsackie/adenovirus receptor lacking a cytosolic domain (39, 
40). All the three strains were housed in a specific pathogen-free 
animal facility at the Institute of Molecular Genetics (Prague, 
Czech Republic).
antibodies and reagents
For western blotting, mouse anti-RACK1, rabbit anti-pY394Lck 
(Santa Cruz), anti-pY505Lck (Cell signaling), mouse anti-Lck 
(3A5), and phosphotyrosine-specific platinum 4G10 mAb 
(Millipore) were used. Mouse anti-α-actinin-1 (BM-75.2), 
rabbit anti-RACK1 C-end, anti-GAPDH, and cholera toxin–
horseradish peroxidase (HRP) conjugate were purchased from 
Sigma-Aldrich, anti-α-tubulin from GeneTex, and anti-GADS 
and anti-LASP from Millipore. Mouse anti-rabbit and goat anti-
mouse HRP light chain-specific antibodies (Jackson IRLab) were 
used for protein detection after immunoprecipitation (IP). For 
IP purposes, antibodies were coupled to Protein A or G magnetic 
beads (Millipore) or the bead-conjugated anti-RACK1 from 
Santa Cruz were used. Biotinylated anti-mouse CD4 (GK1.5) and 
biotinylated anti-mouse TCRβ (H57) mAbs were purchased from 
eBiosciences (USA). For immunofluorescence, CellTrace™ Far 
Red DDAO-SE and Alexa Fluor 488, 555, or 647 goat anti-mouse 
IgG or goat anti-rabbit IgG (H + L) were used. Actin filaments 
were visualized by Alexa Fluor 488 Phalloidin purchased from 
Life Technologies. Streptavidin, Brij58 (polyoxyethylene-20-ce-
tyl-ether), and nocodazole were purchased from Sigma-Aldrich. 
Latrunculin B, lauryl maltoside (n-dodecyl-β-d-maltoside, 
LM), and Src-family kinase inhibitor PP2 were obtained from 
Calbiochem (Merck). Ultrapure grade paraformaldehyde 
(PFA) was obtained from Polysciences. OVA323–339 peptide from 
GenScript Corporation, and staphylococcal enterotoxin E (SEE) 
was purchased from Toxin Technology.
cell lines, cell Preparation, and culture
The NIH3T3 cell line and Lck infectants cell lines were main-
tained in Iscove’s modified Dulbecco’s medium (IMDM), WT, 
and JCAM1.6 The Jurkat T-cell line and RAJI B-cell line were 
cultured in RPMI 1640 (Life Technologies). Both media were 
supplemented with 10% inactivated fetal calf serum (FCS) and 
100 U of penicillin/10 μg streptomycin antibiotics (Sigma) per 
1 ml of media. Bone marrow-derived dendritic cells (BMDCs) 
from OTII transgenic mice were isolated from mice femur and 
tibia cavities. The cells were cultured for 6 days in RPMI medium 
supplemented with GM-CSF-containing supernatant, which was 
produced by the LUTZ cell line (final concentration was adjusted 
to 30 ng/ml). After 3 days of cultivation, one half of the media was 
replenished, and on day 6, the cells were harvested and used for 
further experiments.
cDna Vectors
Lck constructs, described previously (21), were inserted into the 
murine stem cell virus (MSCV)-based internal ribosome entry 
site (IRES)-enhanced green fluorescent protein virus MigR1 
(41), permitting the concurrent expression of a given gene and 
EGFP. EGFP–RACK1 and mCitrine–RACK1 was a gift from 
Dr. Vomastek, and CFP–Lck (clone W25) was a gift from Dr. 
Stockinger (42). Generation of retrovirus packaging cell lines 
and retrovirus stock as well as the infection of NIH3T3 or Jurkat 
T-cells was performed as outlined elsewhere (43, 44). Successfully 
infected cells were sorted to the comparable protein expression 
level of the desired gene.
isolation and activation of Primary T-cells
The procedure was performed as previously described (14). Briefly, 
primary lymph node CD4+ T-cells (~95% purity) were isolated 
from mice using MACS CD4+ T-cell isolation kit (AutoMACS, 
Miltenyi Biotec). CD4+ T-cells were precoated with biotinylated 
anti-TCR (1 μg/ml, clone H57) and anti-CD4 (0.3 μg/ml, clone 
GK1.5) antibodies in 500 μl of PBS + 3% FCS for 30 min at 4°C, 
washed, and resuspended in 20 μl of PBS + 1% FCS per tube or 
were indicated in 20 μl of PBS + 1% FCS + 20 μM PP2. Cells 
were pre-warmed in 37°C, and co-aggregation-mediated activa-
tion was achieved with the addition of streptavidin to a final 
concentration of 50 μg/ml. Cells were vortexed and incubated at 
37°C for the indicated period of time. The activation was stopped 
with the addition of either ice-cold lysis buffer with indicated 
detergent and inhibitors (see below) or immediately boiled in 
Laemmli sample buffer.
cell lysis and immunoprecipitation
Cell lysis of CD4+ T-cells was performed in TKM (50 mM Tris, 
pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM EDTA, 0.5% Brij58) 
or TNE (50 mM Tris, pH 8, 12.5 mM EDTA, 1% NP-40) lysis 
buffer supplemented with protease and phosphatase inhibitor 
cocktails (Roche). Lysates were incubated on ice for 30  min, 
spun down at 800  ×  g for 2  min (removal of nuclei), and 
used for further applications. For RACK1 IPs, the lysates were 
incubated with antibody-precoated RACK1 beads overnight 
at 4°C on a rotational wheel. Beads were then intensively 
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washed (six to eight times), boiled in Laemmli sample buffer 
for 10  min, and immunoprecipitated proteins resolved by 
SDS-PAGE.
Western Blotting and Quantification
Proteins resolved on polyacrylamide gels were transferred onto 
a PVDF membrane (Millipore) and blocked for 1 h in 5% non-
fat milk (for IP) or in 1% BSA in TBS-T at room temperature. 
Blots were then incubated for 1  h with primary antibodies 
diluted in blocking buffer, washed followed by a 1-h incubation 
with secondary antibodies conjugated to HRP, and developed 
by incubation with ECL substrate (Thermo Scientific). Where 
indicated, densitometry quantification was performed by AIDA 
image analyzer software from raw image data obtained from a 
GS-800 Biorad densitometer scanner.
immunofluorescence Microscopy
For immunofluorescence, the staining protocol was adopted from 
the website www.cellsignal.com with some modifications. Briefly, 
CD4+ T-cells were seeded on poly-l-lysine-coated coverslips and 
allowed to adhere for 15 min at 37°C, 5% CO2 followed by cell 
fixation in 4% PFA for 15  min. The following procedure was 
applied to all cell types. After PFA fixation, the cells were permea-
bilized with ice-cold methanol for 10 min in −20°C (methanol 
step had to be omitted when phalloidin was used to stain actin 
cytoskeleton). The cells were blocked for 1 h with PBS containing 
0.3% Triton X-100 (PBT) with the addition of 2.5% FCS and 2.5% 
BSA and incubated with primary and secondary antibodies for 
1 h consecutively. Where indicated, cells were stained with DAPI 
for 10 min. Coverslips were mounted using 4% n-propyl gallate 
in glycerol. Samples were analyzed by sp5 confocal microscopy 
(Leica) or N-SIM super-resolution microscopy (Nikon). Image 
reconstruction was performed by Huygens Professional (SVI) 
or NIS elements (Nikon) software. Image post-editing and 
image analysis including computing of Pearson’s colocalization 
coefficient (PCC) were done with Fiji imaging software and its 
plug-in JACoB.
Preparation of aPc–cD4+ T-cell 
conjugates
The preparation of conjugates for microscopic analysis of IS 
formation in vitro was performed as previously described (45). 
Briefly, BMDCs were prepared in parallel as described above. 
Cells were then pulsed with OVA323–339 peptide for 2 h and TCR-
transgenic CD4+ primary T-cells isolated from OTII mice were 
admixed with APCs at 3:1 ratio. The formation of APC–T-cell 
conjugates was achieved by short centrifugation. Conjugates were 
incubated in serum-free RPMI medium at 37°C. The cells were 
fixed with 4% PFA for 15 min, stained with anti-RACK1 and anti-
Lck, and used for the microscopy analysis.
Formation of raJi–Jurkat-cell 
conjugates, live cell imaging
The WT or Lck-deficient Jurkat T-cell line JCAM1.6 was retrovi-
rally transfected with either an EGFP–RACK1 or CFP–Lck con-
struct, respectively. In addition, the mCitrine–RACK1 construct 
was electroporated (BTX ECM 830, 300 V, 10 ms, 4 mm cuvette) 
into CFP–Lck stable infectants. Jurkat T-cells that were positive 
for both CFP and mCitrine were sorted (BD, Influx cell sorter) 
and rested for 1 day in 37°C/CO2. The formation of RAJI–Jurkat 
conjugates using live cell imaging was performed as previously 
described (46). Briefly, RAJI cells, serving as APCs, were labeled 
with DDAO-SE (Life Technologies), then loaded with 1 μg/ml 
SEE, and transferred into cover glass chamber (Ibidi). CFP–Lck/
mCitrine–RACK1 Jurkat T-cells were subsequently added at a 1:1 
ratio. Cells were observed in a 37°C/CO2 climate chamber using 
a DeltaVision Core/Olympus IX71 microscope under CFP/YFP/
mCherry filter cubes. Images were acquired every 15  s. Image 
post-editing and time-lapse movies were done with Fiji imaging 
software.
Quantification of Fluorescence in 
Microscopic images
To analyze the concentricity and apposition of RACK1 and Lck 
(or GADS), the distance from the centroid of the cell to the cell 
edge was measured using a fluorescent intensity profile (see details 
in Figure S1 in Data Sheet 1 in the Supplementary Material). All 
microscopic quantitative analyses were performed by ImageJ 
program. Statistical analyses were performed with GraphPad 
Prism 5 using a paired two-tailed t-test.
Quantitation of the recruitment of RACK1 to the IS was 
calculated as described previously (47). Briefly, using the selec-
tion brush tool in ImageJ program, the T cell area adjacent to the 
synapse region, outside synapse region and the background area 
outside of the cell, was demarcated. The relative recruitment index 
(RRI) was calculated as the [mean fluorescence intensity (MFI) 
at synapse region minus the background]/[MFI of the outside 
synapse region minus background]. Quantitative measurements 
of MFI were performed with the program ImageJ. Statistical 
analysis was performed with GraphPad Prism 5 using a paired 
two-tailed t-test.
gel Filtration
This size-exclusion chromatography procedure is based on a 
previously described protocol (48) with slight modifications (14). 
Briefly, a 5-ml pipette tip plugged with a small piece of glass wool 
and filled with Sepharose 4B beads (Sigma-Aldrich) was used 
as the column. Cells were lysed in TKM-Brij58 lysis buffer for 
30 min and spun down for 2 min at 800 × g. Supernatant at a total 
volume of 1/10 of the stationary bead volume was loaded onto the 
top of the column and eluted with cell lysis buffer. All steps were 
performed at 4°C. In this setting, fraction #4 contains complexes 
of >107 Da; most of the pentameric IgM and IgG standards eluted 
in fractions #7 and #9, respectively (48).
isolation of Detergent-resistant 
Membranes
The isolation of DRMs was performed as described previously 
(14, 16). For the assessment of protein distribution in fractions 
obtained by gel filtration, pooled fractions were mixed 1:1 with 
80% sucrose and subjected to the same protocol. Light DRMs, 
corresponding to classical LRs, are enriched in top fractions 
(#1–3), while the bottom fractions (#8–10) concentrate heavy 
DRMs together with soluble proteins.
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cytosketal inhibitors
For assessing the involvement of cytoskeletal components in the 
redistribution of Lck after TCR/CD4 aggregation, CD4+ T-cells 
were resuspended in PBS + 3% FCS and treated with either 2 μg/
ml of latrunculin B or 10 μM of nocodazole for 30 min in 37°C 
and 5% CO2. Subsequent precoating of the cells and TCR/CD4 
co-aggregation were also performed in the presence of these 
inhibitors on ice. Before activation, small aliquots of latrunculin 
B- and nocodazole-treated samples, as well as untreated controls 
sample, were pre-warmed and fixed at 37°C with PFA for 15 min, 
stained as described above, and analyzed by microscopy.
adenoviral Vectors and Transduction of 
Tgcar T-cells
Adenoviral vectors and virus particles containing shRNA hair-
pins, as well as control empty vector/viruses, were prepared using 
the Knockout RNAi system and the Adeno-X Expression system 
1 (Clontech) and used according to the manufacturer’s protocol. 
Target sequences of shRNA for RACK1 are as follows: RAO#2-
gcaagatcattgtagatgaat, RAO#4-ctcccacttcgttagtgat, and RAO#5-
ggatgagagtcattcagaatg. Transduction of T-cells was performed as 
described elsewhere (49). Briefly, isolated naïve CD4+ T-cells were 
resuspended in DMEM medium containing 2% FCS and desired 
MOI of adenoviral particles and incubated at 37°C/CO2 for 1 h. 
Then, the cell/virus mixture was transferred to a culture dish 
and incubated for the indicated time at 37°C/CO2 in complete 
RPMI media supplemented with 2 ng/ml of rmIL-7 (PeproTech). 
Then, live T-cells were sorted, rested for 4 h, and used for further 
experiments.
Mass spectrometry
The stained protein bands were processed according to the 
standard protocol generally used for mass spectrometry (MS) 
protein identification (50) with minor modifications. The gel 
slices containing the proteins of interest were washed, proteins 
reduced with dithiothreitol, alkylated with iodoacetamide, and 
digested with trypsin. The extracted peptides were separated 
using a home-made microgradient device (51) with C18 
reversed phase capillary column (i.d. 200 μm, length 70  mm) 
for LC MALDI-TOF/TOF MS and MS/MS analysis using 4800 
Proteomics Analyzer (Applied Biosystems, Framingham, MA, 
USA) with α-cyano-4-hydroxycinnamic acid as MALDI matrix. 
Protein database identification was carried out with Protein Pilot 
2.0 software using the SwissProt part of the UniProt database 
server.
resUlTs
localization of lck and racK1 in cD4+ 
Primary T-cells
First, we determined the expression of RACK1 in mouse primary 
lymph node CD4+ T-cells. RT-PCR analysis performed on total 
mRNA isolated from FACS-sorted cells (99.3% purity) demon-
strated detectable levels in non-activated CD4+ T-cells (data not 
shown). Confocal microscopy confirmed the presence of RACK1 
on the protein level and showed that Lck is localized almost 
exclusively to the plasma membrane. We observed that RACK1 
is positioned just beneath Lck, in a constrained cytoplasmic niche 
between the plasma membrane and nucleus, the latter fulfilling the 
vast majority of intracellular space (Figure 1A). To assess RACK1 
subcellular distribution more accurately, we performed super-
resolution microscopy. It confirmed that in resting CD4+ T-cells, 
Lck and RACK1 are juxtaposed concentrically (Figures 1B–D) 
and exhibit a mild overlap (Figure 1E) in accordance with the 
PCC >0.6 (Figure 1F).
racK1 and lck co-redistribute to 
Forming immunological synapse
Next, we assessed the cellular co-distribution of RACK1 and Lck 
in activated primary lymph node CD4+ T-cells during early phases 
of IS formation. Microscopic examination of cell conjugates of 
OVA peptide-pulsed BMDCs with transgenic T-cells specific 
for OVA peptide showed that Lck and RACK1 concomitantly 
translocated to and enriched in IS at early phases of its formation 
(2–5 min) (Figures 2A,B). Lck, the accumulation of which in IS 
has been previously demonstrated (20, 45), was used as an internal 
control. Interestingly, we observed that RRI for RACK1 is even 
higher than that for Lck, strongly suggesting the physiological 
importance of RACK1 enrichment in the forming IS (Figure 2B).
To analyze the co-redistribution of RACK1 and Lck during 
early phases of IS formation in more detail, we performed experi-
ments that would visualize the kinetics of this process. Toward 
this end, Jurkat T-cells, which are able to form cell conjugates 
with RAJI cells were infected with a RACK1–EGFP retroviral 
construct, and the kinetics of RACK1–EGFP translocation into IS 
was examined in a time-dependent manner using live fluorescent 
microscopy (Figure 3A; Video S1 in Supplementary Material). 
RACK1–EGFP protein was found moderately enriched in the 
forming IS (Figure 3B) with the total time of its transient resi-
dency from 6 min to more than 18 min (Figure 3C).
To visualize the Lck and RACK1 co-redistribution event, 
we co-transfected Jurkat T-cells with two constructs: RACK1–
mCitrine and Lck–CFP. mCitrine and CFP double-positive cells 
were FACS-sorted, and time-lapse images were recorded (Video 
S2 in Supplementary Material). As presented in Figure  3D, 
shortly after conjugate formation (1–2 min, see the arrow in the 
2 min time frame), RACK1 and Lck co-redistributed to the form-
ing IS where they both persisted for several minutes. Between 6 
and 8 min, RACK1–mCitrine slowly moved distally from IS. At 
the 9-min mark until 11 min (Figure 3D, bottom two rows of 
images), suddenly and rapidly RACK1–mCitrine re-translocated 
back to the bulk volume of cytoplasmic space of the T-cell, leav-
ing Lck behind in the IS where it remained for at least 7–8 min 
(Figure 3E). It is of note that the Jurkat T-cell which appears in 
the upper right hand corner of the 2-min image of the time-lapsed 
video and image and in which the amount of RACK1–mCitrine 
markedly exceeded that of Lck–CFP (red color is below the visible 
range) displays similar kinetics of RACK1 translocation to the IS 
and reverse re-translocation back to the cytoplasm as described 
above (Figure 3D; Video S2 in Supplementary Material).
Taken together, these data suggest that T-cell activation 
induces a rapid, cooperative, and IS-directed movement of 
Lck and RACK1. This co-redistribution pattern provided the 
FigUre 1 | subcellular distribution of lck and racK1 in primary cD4+ T-cell. Fixed CD4+ T-cells were stained for RACK1 (green), Lck (red), and nuclei (blue) 
and visualized by confocal microscopy (a) or super-resolution N-SIM microscopy (B). (c) Fluorescence intensity profile plot of Lck (red) and RACK1 (green) along 
the dotted line shown in the merged image of figure (B). (D) Statistical analysis of the concentric juxtaposition of Lck and RACK1, which shows a larger distance of 
Lck from the cell centroid to its periphery (n = 30), p ≤ 0.0001. (e) Magnification of the rectangle inset from the Merge image presented in (B) showing a 
subconcentrical juxtaposition of RACK1 to membrane-bound Lck. (F) The bar graph represents the statistical analysis of Lck and RACK1 colocalization using 
Pearson’s colocalization coefficient (n = 20 cells). Error bars denote SD.
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first evidence that RACK1 could participate in the mecha-
nism guiding the redistribution of membrane Lck upon TCR 
engagement.
racK1–lck complex Formation in the 
Primary cD4+ T-cells
To determine if RACK1 is involved in proximal T-cell signaling 
via its interaction with Lck and if it is constitutive or activation 
inducible, we utilized the model of antibody-mediated T-cell 
activation enabling to study the kinetics of interaction between 
two interacting proteins during the first seconds after TCR/CD4 
co-aggregation (14, 16) (Figure 4A). On average, a threefold to 
sixfold enrichment of Lck in complexes with RACK1 reached its 
maximum level 10  s after TCR–CD4 engagement (Figure  4B). 
Then, in the following 30–90  s, these levels diminished to 
those observed in non-activated cells (Figures  4A and 5A,C). 
Consistent with the colocalization analysis (Figures 1C–F) only 
low, background levels of RACK1–Lck complexes were detected 
in the non-precoated control sample (Figures 4A and 5A, “non-
precoated” lane).
subcellular Distribution of racK1–lck 
complexes
We recently demonstrated that a small preactivated pool of 
pY394Lck, which plays an important role in TCR triggering in 
resting primary CD4+ T-cells, associates with an LM-sensitive 
type of membrane microdomains called heavy DRMs (14). 
This high molecular weight (HMW) fraction can be obtained 
from Brij58 detergent-solubilized cells by gel filtration (53, 54). 
Interestingly, it is the heavy DRM-associated pool of Lck which, 
upon TCR/CD4 engagement, not only significantly increases its 
kinase activity but also exclusively translocates to distinct types 
of microdomains called light DRMs (14, 55). These considera-
tions led us to assess the subcellular distribution of RACK1 in 
CD4+ T-cells. As illustrated in Figure 4C, RACK1, similar to the 
pool of pY394Lck, is enriched in the complexes that are associated 
FigUre 2 | lck and racK1 in primary cD4+ T-cell co-redistribute into forming immunological synapse. (a) OVA-pulsed bone marrow-derived dendritic 
cells (BMDCs) were mixed with CD4+ T-cells from OTII transgenic mice. After 2–3 min, T-cell–APC conjugates were seeded on cover slips, fixed and probed with 
anti-Lck (red) and anti-RACK1 (green), and visualized by super-resolution N-SIM microscopy. The upper two panels show the fluorescence intensities of individual 
Lck or RACK1 signals using pseudocolor digital scaling. The panel titled “Detail” shows the magnification of the rectangle inset seen in the Merge image. An image 
of one representative cell conjugate is presented. Consistent with a previous report (52), the low expression of Lck was also detected in BMDCs. (B) Statistical 
analysis of the relative recruitment index (RRI) showed that while both RACK1 and Lck are enriched at the site of the forming IS, RRI for the former is significantly 
higher than that for Lck (n = 20), p < 0.01.
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with high HMW fractions #4–6. Next, we assessed the physical 
association of Lck and RACK1 in the fractions that were prepared 
from resting and activated T-cells. As shown in Figure 4D, the 
immunopreciptation of RACK1 from pooled HMW fractions 
#4 + 5 and #6 + 7 confirmed the activation-induced formation 
of RACK1–Lck complexes that were detected only in fractions 
#4 + 5 that were prepared from activated T-cells. These results 
suggest that in resting T-cells, the pool of preactivated pY394Lck 
and RACK1 are in physical proximity by co-distributing to heavy 
DRMs, which spatially restricts their transient interaction upon 
TCR activation. These data thus support the prediction that upon 
TCR/CD4 triggering, RACK1 can bind a spatially restricted pool 
of kinase active Lck and functions as a transportation vehicle that 
assists the redistribution of Lck to light DRMs, as documented 
previously (14, 16).
structure–Function analysis of racK1–
lck interaction
Next, we sought to determine which domain or tyrosine residue, 
which regulates Lck kinase activity, mediates its interaction with 
RACK1. Toward this end, we prepared a NIH3T3 fibroblast cell line 
expressing wild type Lck (WT), constitutively active Lck (Y505F) 
and Y505F Lck backbone with additionally inactivated either 
SH3 (W97K) or SH2 (R154K) domain (Figures S2A–C in Data 
Sheet 1 in the Supplementary Material). Endogenous RACK1 was 
immunoprecipitated with anti-RACK1 antibody, and its aliquots 
were blotted for Lck and RACK1. We found that in NIH3T3 cells, 
the WT, Y505F, and even kinase compromised Y505F/Y394F Lck 
interacted comparably with endogenous RACK1. However, this 
complex formation was nearly abolished in the variant expressing 
non-functional SH3 domain and severely compromised in the 
SH2 mutant of Y505F Lck (Figures 4E,F). This suggests that the 
presence of both functional modular SH3 and SH2 domains of 
Lck is a prerequisite for RACK1–Lck complex formation.
racK1 complexes with lck regardless of 
lck activation status
The above results revealed that RACK1–Lck complex formation, 
at least in fibroblast cells, proceeds irrespective of the activation 
status of Lck (Figure 4E, Y505F versus Y394F/Y505F Lck). We 
next assessed if such a mode of interaction would also occur 
in primary CD4+ T-cells. As shown in Figure  5A, the kinetics 
of TCR/CD4 co-aggregation allowed the IP of RACK1–Lck 
complexes, which contain detectable levels of pY394Lck. Their 
highest levels were observed at 5–10 s after activation (Figure 5A, 
pY394Lck panel, and Figure  5B), whereby the latter time point 
correlated with the peak of enrichment of Lck in these complexes 
(Figure 5A, Lck panel, and Figure 5C). This would suggest that 
a TCR/CD4-induced increase in pY394Lck precedes and thus 
predicates the formation of RACK1–Lck complexes. However, 
the activation-induced RACK1–Lck complex formation was 
not ablated in T-cells that were pretreated with the SFK kinase 
inhibitor, PP2, which effectively inhibited the activation-induced 
global tyrosine phosphorylation of TCR downstream sub-
strates (Figure  5D, 4G10 bottom panel, right lane, PP2+) and 
blocked the activation-induced enhancement of pY394Lck levels 
(Figure 6D, pY394Lck panel, PP2+). Together, these biochemical 
results strongly suggest that the physical interaction between 
FigUre 3 | The kinetics of lck and racK1 co-redistribution into forming immunological synapses (is) in Jurkat T-cells. (a) Jurkat T-cells expressing 
RACK1–EGFP (green) were mixed with SEE-pulsed RAJI B-cells (denoted by the dotted circle), and the redistribution of RACK1 was observed by live cell imaging 
microscopy. Sequential time-lapse fluorescence microphotographs from one representative movie (Video S1 in Supplementary Material) are shown. (B) Statistical 
analysis of the kinetics of the relative recruitment index (RRI) of RACK1 to the forming IS measured after cell contact initiation (n = 20). (c) The bar graph shows the 
time distribution of RACK1 residency in IS; the start and end points of RACK1 residency are marked by two white arrows shown in (a); n = 20 cells. (D) Lck-
deficient JCAM1.6 Jurkat T-cells co-expressing Lck–CFP (red) and RACK1–mCitrine (green) constructs were mixed with SEE-pulsed RAJI B-cells (blue). Their 
redistribution during the formation of IS was observed by live cell imaging microscopy. Sequential time-lapse fluorescence microphotographs from one 
representative movie (Video S2 in Supplementary Material) are shown. An arrow points to the forming IS. (e) Statistical analysis of the kinetics of the relative 
recruitment index (RRI) of RACK1 and Lck to the forming IS measured after cell contact initiation (n = 20).
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FigUre 4 | antibody-mediated engagement of Tcr/cD4 receptors induces racK1–lck complex formation in primary cD4+ T-cells. (a) CD4+ 
T-cells precoated or non-precoated with biotinylated anti-TCR and anti-CD4 mAbs (TCRβ/CD4) were co-aggregated, or not (0 s), with streptavidin for the 
indicated time. RACK1 immunoprecipitates were blotted against Lck and RACK1. The bar graph at bottom shows the relative amount of co-immunoprecipitated 
Lck after normalization to RACK1. (B) The graph plot presents the relative fold increase of co-immunoprecipitated Lck (10 s after activation) from six 
independent experiments. The statistical analysis presented as mean ± SD was performed using the Student’s two-tailed t-test, **p < 0.01. (c) RACK1–Lck 
interaction is localized into HMW fractions. CD4+ T-cells fractions (#3–12) obtained from a Sephadex column were probed with anti-Lck, anti-pY394Lck, 
anti-RACK1, and cholera toxin B subunit–HRP, which detects the surrogate marker of light DRMs, GM1. The fraction elution profile of the molecular weight size 
marker is shown on the top. (D) Fractions #4–5 and #6–7 from non-activated (precoated) or activated (TCRβ/CD4, 10 s) CD4+ T-cells were pooled, 
immunoprecipitated with anti-RACK1, and blotted with anti-Lck and RACK1 antibody. (e) RACK1–Lck interaction depends on functional SH2 and SH3 Lck 
domains. Endogenously expressed RACK1 was immunoprecipitated from NIH3T3 Lck infectants and blotted with anti-Lck and anti-RACK1 antibodies. 
(F) Statistical analysis of (e) represents the relative fold-change of RACK1 co-immunoprecipitated Lck variants from three independent experiments. The 
statistical analysis presented as mean ± SD was performed using the Student’s two-tailed t-test, **p < 0.01, n.s., not significant. Blots shown in (c–e) are 
representatives of at least three independent experiments.
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Lck and RACK1 is independent of the activation status of Lck. 
However, under normal circumstances during TCR/CD4 engage-
ment, upon which the preactivated pool of Lck is significantly 
increased (56), these complexes contain a sizeable fraction of 
pY394Lck (Figure 5A).
identification of additional components 
of racK1 complexes in cD4+ T-cells
Our observation that the formation of RACK1–Lck complexes was 
dependent on both the SH2 and SH3 domain of Lck (Figure 4E) 
suggested that this interaction could be indirect and involved 
additional structural components. Consistent with this notion are 
results from our pull-down experiments using in vitro translation 
that failed to show direct RACK1–Lck binding (data not shown). 
To gain added insight into the complexity of RACK1–Lck 
interaction, we first assessed the presence of additional compo-
nents in RACK1 immunoprecipitates from activated primary 
CD4+ T-cells. To recognize their presence in immunoprecipitated 
RACK1 complexes, we took advantage of the fact that TCR sign-
aling is a tyrosine phosphorylation (pY)-driven event, and thus, 
at least those components of RACK1 complex which change their 
pY status could be readily detectable.
As illustrated in Figure 6A, several tyrosine phosphorylated 
proteins co-immunoprecipitated with RACK1. Specifically, we 
found four major phosphoproteins in activated T-cells, three of 
which possessed the molecular weights (MWs) of ~100, ~70, 
and ~38 kDa, and their pY status was associated with RACK1 
in an activation-inducible manner. The fourth phosphoprotein 
which possessed an MW of ~56 kDa matched the MW of Lck. 
To reveal the identity of the former three phosphoproteins, the 
FigUre 5 | racK1–lck complexes can form irrespective of lck kinase activity, but those from activated T-cells contain a sizeable fraction  
of pY394lck. (a) CD4+ T-cells precoated or non-precoated with biotinylated anti-TCR and anti-CD4 mAbs (TCRβ/CD4) were co-aggregated, or not (0 s), with 
streptavidin for the indicated period of time. RACK1 immunoprecipitates were blotted against pY394Lck, total Lck, and RACK1. (B,c) Statistical analysis of 
pY394Lck and total Lck blots from (a), respectively, represent the normalized to total RACK1 from at least three independent experiments. The statistical 
analysis presented as mean ± SD was performed using the Student’s two-tailed t-test, *p < 0.05, **p < 0.01, n.s., not significant. (D) CD4+ T-cells were 
pretreated, or untreated, with SFK inhibitor (PP2+), TCRβ/CD4 co-aggregated, and lysed in TNE lysis buffer. RACK1 was immunoprecipitated and aliquots 
blotted against total Lck and RACK1; total cell lysates were blotted with anti-pY 4G10 antibody. Blots shown in (a,D) are representative of at least three 
independent experiments.
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corresponding areas from a coomassie-stained gel were excised 
and their protein content subjected to MS analysis (Table S1 in 
the Supplementary Material). Due to the fact that RACK1 is a 
scaffold protein that plays an essential role in transcription, 
epigenetics, and translation as well as binds diverse signaling and 
structural proteins, we zoomed in on those proteins that poten-
tially act outside these activities. Among them, we focused on 
proteins that were known to be involved in proximal TCR signal-
ing and cytoskeleton regulation of the forming IS (Figure 6B). 
The capacity of these candidate proteins to bind RACK1 before 
and after T-cell activation was assessed. GADS, LASP1, and 
α-actinin-1 exhibited sizeable changes in the kinetics of interac-
tion with RACK1 upon TCR/CD4 co-aggregation. Notably, while 
α-actinin-1 binds to RACK1 with increasing intensity (from 0 
to 90 s, Figure 6C, upper panel), the level of RACK1 interaction 
with GADS and LASP1 was diminished with similar kinetics over 
the time tested (Figure 6C, GADS and LASP1 panels). RACK1–
GADS complex formation in resting primary T-cells was micro-
scopically corroborated by their colocalization in resting T-cells 
(Figure S3 in Data Sheet 1 in the Supplementary Material).
Only Kinase active lck–racK1 
complexes Bind α-actinin-1
While RACK1 interactome involves unusually high number of 
partners (BioGRID database; http://thebiogrid.org), the binding 
of α-actinin-1 to RACK1 complexes is an original finding. Actinins 
are primarily considered to be actin-cross-linking proteins but 
can also link transmembrane proteins to the cytoskeleton and 
membrane trafficking events (57). Our data showed that in rest-
ing CD4+ T-cells, α-actinin-1 inducibly associates with RACK1 
upon TCR/CD4 co-aggregation (Figure 6D, TCRβ/CD4, 0 versus 
10 s, α-actinin-1 panel, and Figure 6E). However, as described 
above, while RACK1–Lck complex formation proceeds even 
in the presence of SFK inhibitor PP2 when Lck kinase activity 
is severely compromised (Figure  6D, TCRβ/CD4, 10  s/PP2+, 
pY394Lck panel), binding of this complex to α-actinin-1 is blocked 
(Figure  6D, last lane, α-actinin-1 panel, and Figure  6E). This 
advocates for a scenario in which TCR/CD4 co-ligation induces 
the formation of complexes which contain RACK1 and kinase 
active Lck (Figure 5A), the latter required for linking these com-
plexes to α-actinin-1 component within the cytoskeleton. If Lck 
FigUre 6 | identification of additional components of racK1–lck complexes. (a) RACK1 immunoprecipitates from non-activated (0 s) and activated (10 s) 
CD4+ T-cell samples, and beads alone, were probed with anti-pY antibody (4G10). The arrows point to areas that show readily detectable phosphoproteins 
co-immunoprecipitating with RACK1. In the coomassie blue-stained gel, the areas depicted by arrows from all three samples were extracted (except for the 55-kDa 
area) and subjected to MALDI TOF/TOF MS analysis. A selected list of size-related and identified proteins with their potential pY sites are shown in (B). The bead 
sample was negative for these proteins. (c) The kinetics of complex formation between RACK1 and indicated proteins before (0) and at the indicated time points 
after TCRβ/CD4 co-aggregation. RACK1 immunoprecipitates were probed with anti-α-actinin-1, anti-GADS, anti-LASP, anti-Lck, and anti-RACK1. (D) CD4+ T-cells 
were treated (PP2+) or not with PP2 inhibitor, activated, and lysed in TNE lysis buffer. RACK1 was immunoprecipitated, and samples were blotted against Lck, 
pY394Lck, α-actinin-1, and RACK1. (e) Statistical analysis of (D), actinin-1 panel, represents the relative fold change of RACK1 co-immunoprecipitated actinin-1 
normalized to total RACK1. The statistical analysis presented as mean ± SD was performed using the Student’s two-tailed t-test, *p < 0.05, n.s., not significant. 
Blots shown in (c,D) are representative of three independent experiments.
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activity is blocked, the formation of RACK1–Lck complexes still 
proceeds, but α-actinin-1 is not engaged.
Destabilization of Microtubules Prevents 
racK1–lck complex Formation
The timely and spatially coordinated complex formation between 
Lck and RACK1 in heavy DRM, their co-redistribution to the 
forming IS and linkage to α-actinin-1 suggest that the cytoskel-
etal network is actively involved. We have also reported that the 
activation-induced translocation of Lck to light DRMs is blocked 
by nocodazole, an inhibitor of microtubular assembly (14). To 
further investigate the potential involvement of RACK1 in the 
microtubular network-assisted translocation of Lck, we assessed 
the effect of nocodazole treatment on RACK1–Lck complex 
formation. The results showed that nocodazole, but not latrun-
culin-mediated inhibition of the actin cytoskeleton, effectively 
blocked the formation of RACK1–Lck complexes (Figure  7A, 
Lck panel, and Figure 7B). Of note, while lantrunculin and noco-
dazole treatment effectively disrupted the actin and microtubular 
network, respectively (Figure 7C), the activation-induced global 
tyrosine phosphorylation in the presence of these inhibitors was 
comparable to the untreated control sample (Figure  7A, bot-
tom panel, 4G10). These data potentially provide a mechanistic 
explanation for the activation-dependent redistribution of Lck 
to light DRMs by virtue of linking the TCR/CD4-Lck complex 
to the microtubular cytoskeletal network via RACK1. This also 
suggests that at the very early stages of T-cell engagement, actin 
cytoskeleton does not affect Lck mobility even though α-actinin, 
FigUre 7 | Functional microtubular network is important for racK1–lck complex formation upon T-cell activation. (a) CD4+ T-cells were pretreated 
with latrunculin B (LAT B), nocodazole (NOC), or DMSO (control) and then activated for the indicated period of time followed by lysis in TNE lysis buffer. RACK1 was 
immunoprecipitated and blotted against Lck and RACK1. Samples from lysates before IP were boiled and subjected to pY western blot analysis with 4G10 
antibody. Blots are representative of three independent experiments. (B) Statistical analysis of (a), Lck panel, represents the relative fold-change of RACK1 
co-immunoprecipitated Lck normalized to total RACK1. The untreated control samples were given reference value “1.” The statistical analysis presented as 
mean ± SD was performed using the Student’s two-tailed t-test, *p < 0.05, n.s., not significant. (c) CD4+ T-cells treated with DMSO (control); nocodazole or 
latrunculin B were pre-warmed at 37°C and fixed by PFA on polylysine coverslips. Tubulin (red) and actin (green) were visualized by confocal microscopy. Nuclei 
were stained with DAPI (blue). Representative images show the maximal intensity projection (MIP) of z-stacks.
12
Ballek et al. RACK1 in TCR Signaling
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 449
which can potentially crosslink actin microfilaments, is already 
part of the Lck redistribution machinery.
Knockdown of racK1 hinders activation-
induced lck Translocation to lr
We next attempted to evaluate the potential functional relevance 
of RACK1–Lck interaction for the redistribution of Lck to 
light DRMs (16). CD4+ T-cells from TgCAR transgenic mice 
expressing the receptor for adenovirus on T-cells were infected 
with adenovirus containing shRNAs to downregulate RACK1 
(Figure 8A). After 96 h of adenovirus infection, the cells were 
harvested and activated by TCR/CD4 co-aggregation. The dis-
tribution of Lck to light DRMs was then compared to cells that 
were infected with a mock construct. Regardless of the technical 
caveats that are associated with our limited ability to consistently 
generate viable RACK1 knockdown (KD) immune cells (see 
commentary in Figure S4 in Data Sheet 1 in the Supplementary 
Material), our data showed that in activated T-cells, the reduced 
levels of RACK1 correlated with diminished redistribution rate 
of Lck to light DRMs (Figure  8B). These results points to the 
potential involvement of RACK1-based multiprotein signaling 
network in Lck redistribution during proximal T-cell signaling.
DiscUssiOn
The overarching goal of our investigation was to provide the 
initial insight into the molecular mechanism involved in the early 
 recruitment of Lck to light DRMs and the forming IS. As  targeting 
Lck to light DRMs predicates enhanced TCR-mediated IL-2 
production (21) and alternations in the association of Lck with 
accessory molecules within light DRMs supports abnormal 
T-cell signaling in autoimmune diseases (58), elucidation of the 
nature of this process on the molecular level represents a topic 
of academic and clinical interest. Our data provide compelling 
evidence that RACK1 orchestrates spatial redistribution of Lck 
via tethering to cytoskeletal elements.
Results presented in this study are the first to reveal and char-
acterize the role of RACK1 in early T-cell activation. RACK1–Lck 
FigUre 8 | adenovirus mediated knockdown of racK1 impedes translocation of lck to light DrMs. CD4+ T-cells from TgCAR transgenic mice were 
infected with either empty control virus (Empty) or with a mixture of adenoviral RACK1-targeting shRNA constructs (shRNA) or were not infected (no virus). (a) The 
effectiveness of RACK1 downregulation is shown 96 h after infection. Cells were harvested and probed with anti-Lck and anti-RACK1. (B) CD4+ T-cells infected with 
Empty virus (control) or shRNAs RACK1 virus were activated by TCR/CD4 co-aggregation (30 s), or not (0 s), and the redistribution of Lck to light DRMs was 
assessed. Raft (#1–3, R) and soluble (#8–10, S) fractions were probed with anti-Lck. Numbers represent relative distribution of Lck to these fractions. Blots are 
representative of two independent experiments.
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complex formation in primary CD4+ lymph node T-cells is 
activation-inducible, transient, and wanes shortly after activa-
tion. We have previously shown that only the pool of Lck that is 
associated with the HMW fractions translocates to light DRMs 
(14). Co-purification of RACK1 with these fractions in resting 
T-cells and the confinement of its activation-induced interactions 
with Lck to these fractions is consistent with its involvement in 
the shuffling of Lck to light DRMs. In addition, Lck and RACK1 
co-redistribute with the same kinetics to the forming ISs. This 
argues for the existence of an underlying mechanism by which 
Lck and RACK1 are physically coupled and mechanistically 
transferred to these structures, likely via an association with 
common cytoskeletal elements (34, 59). In this context, our 
biochemical data showed that the formation of RACK1–Lck 
complexes, as well as the subsequent translocation of Lck to light 
DRM (14) depends on an intact microtubular network. While 
the relevant mechanism is obscure, there is precedence for the 
involvement of microtubular network in the proximal T cell 
signaling. As demonstrated previously, microtubules are located 
in close proximity to the cell membrane at the activation site 
and together with dynein regulate early microcluster transport 
and TCR signaling events (60). Thus, it is quite possible that 
microtubules can assist the binding of RACK1 and Lck, directly 
or indirectly, and via an unknown mechanism regulate their 
TCR/CD4-induced redistribution. Importantly, KD of RACK1 
in primary CD4+ T-cells profoundly hampered the translocation 
of Lck to light DRMs. Thus, our data demonstrate that RACK1 
fulfills the role of an adaptor protein that is involved in the regula-
tion of Lck redistribution to light DRMs through the linking of 
TCR/CD4–Lck to the cytoskeletal network.
It has been previously reported that a Src–RACK1 interaction 
occurs through the binding of Src–SH2 domain to the tyrosine 
in position 246 (Y246) in the sixth WD40 domain of RACK1, 
which is phosphorylated by Src itself (32). As Src and Lck share 
the same structural components and domain organization, 
one could assume that RACK1–Lck interaction should also be 
dependent on the SH2 domain of Lck. However, we were unable 
to detect tyrosine-phosphorylated residues (pY) on RACK1 
10  s after TCR/CD4 co-aggregation (data not shown). Thus, it 
is unlikely that RACK1–Lck interaction is mediated via bind-
ing of Lck–SH2 to pY on RACK1. Unexpectedly, RACK1–Lck 
interaction was also abrogated in the SH3-inactivated mutant of 
Lck. This indicates an equal importance of these two domains in 
RACK1–Lck complex formation. However, the structural basis 
for RACK1 binding to SH3–Lck is uncertain. Alternatively, if 
these interactions are mediated through some intermediary, it 
would predict the formation of multiprotein complexes involv-
ing numerous protein–protein interactions. Our data support 
this scenario. Notably, in addition to RACK1, Lck redistribution 
machinery might include the adaptor protein GADS (61) and 
components of the cytoskeleton such as α-actinin (62) and LASP1 
protein (63). Other potential components such as serine/threo-
nine protein phosphatases PP1 and 2A, protein SEC13 homolog, 
F-actin capping protein, Annexin A2, and ERM proteins were 
detected (Table S1 in the Supplementary Material), but validation 
of their presence and potential function in RACK1 complexes in 
T-cell proximal signaling needs further experimentation.
Interestingly, our data showed that Lck formed complexes 
with RACK1, irrespective of its kinase activity status, suggesting 
that conformational changes of TCR and/or CD4 may play a role 
in their induction (64). While the underlying mechanism awaits 
some resolution, we also demonstrated that it is only when these 
complexes contain kinase active Lck, they recruit α-actinin-1. 
The binding of α-actinin-1 to RACK1–Lck complexes adds 
another layer of complexity to the schematic of TCR signal-
ing. Notably, it has been previously reported that α-actinin-1 
associates with the membrane fraction of mouse lymphocytes 
(65) and resides in heavy DRMs of in immune cells (66). It has 
been also shown that α-actinin binds directly to both phosphati-
dylinositol-(4,5) biphosphate (PtdInsP2) and PI-3 kinase which 
when activated, converts PIP2 to phosphatidylinositol-(3,4,5) 
triphosphate [PtdIns(3,4,5)-P3] at the inner leaflet of the 
plasma membrane (67). α-actinin-1 is also a target of activated 
tyrosine kinase (68), the nature of which, in T-cells, has not 
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been elucidated. Interestingly, while α-actinin primarily acts to 
bundle actin filaments, this function upon the initiation of TCR 
signaling would be likely subjected to negative regulation by all 
the three mechanisms mentioned in this study. Notably, binding 
to α-actinin of PtdIns(3,4,5)-P3, which is generated by activated 
PI-3 kinase (69) and tyrosine phosphorylation with increased 
binding of Ca2+ to EF domains of α-actinin (70), would addi-
tively or synergistically reduce actinin’s affinity for actin. Thus, 
while TCR/CD4 engagement recruits α-actinin-1 to RACK1–Lck 
complexes, during proximal T-cell signaling, α-actinin-mediated 
actin bundling would be compromised. However, whether such 
a mechanism in T-cells is indeed operational is currently under 
investigation.
Our data from primary CD4+ T-cells also confirmed a previous 
finding that RACK1 physically associates with GADS in resting 
Jurkat T-cells (71). GADS and SLP76 are critical components of 
the signaling pathway which, upon TCR activation, inducibly bind 
to the phosphorylated scaffold protein LAT (61), which is respon-
sible for subsequent actin cytoskeletal rearrangement (5). While 
speculative, a more plausible scenario would be that after TCR/
CD4 triggering, tyrosine kinases Lck and ZAP70 are activated 
with the latter phosphorylating LAT at multiple sites (pY-LAT). 
The RACK1–GADS–SLP76 complex is then recruited to pY-LAT 
via SH2 of GADS, brought into the proximity of the TCR/CD4 
complex and gains access to activated Lck. RACK1 then dissoci-
ates from GADS and forms multiprotein complexes which include 
several signaling components. Inclusion of kinase active Lck in 
this complex is predicated by the presence of an unperturbed 
microtubular cytoskeleton, which then mediates Lck redistribu-
tion to light DRMs, where Lck phosphorylates Fyn. This model 
is consistent with the kinetics of Lck translocation to light DRMs: 
TCR/CD4 co-aggregation-induced Lck enrichment in light DRMs 
reaches its maximum at 30  s, which correlates with the already 
decreasing amount of activation-induced RACK1–Lck complexes 
(16). Binding of α-actinin-1 to the RACK1 complex exclusively 
in the presence of kinase active Lck suggests that formation of 
RACK1–pY394Lck–α-actinin-1 module acts as a regulatory switch 
for the engagement of actin cytoskeleton upon productive TCR/
CD4 triggering. A precise molecular mapping and structure–
function analysis will be needed to dissect the parameters of this 
transient multiprotein complex formation and its interactome.
Our data also raise a fundamental question concerning the 
spatiotemporal regulation of interaction between microtubular 
and actin cytoskeleton during T-cell proximal signaling. We 
need to take into account evidence that not only the two fila-
ment systems interact with each other in vivo (72) but also that 
α-actinin specifically plays an integral role in the cooperative 
regulation of microtubular and actin cytoskeleton dynamics 
(73–75). In addition, as both RACK1 and α-actinin have been 
implicated in costimulatory and/or adhesion signaling which 
closely follows the TCR triggering event (71, 76, 77), it would be 
not entirely surprising that their TCR-induced complex forma-
tion would integrate signals from multiple receptors, including 
TCR/CD4, CD28, and integrins, and orchestrate the complex 
cooperative microtubular and F-actin cytoskeleton rearrange-
ment. Importantly, as during early phases of TCR signaling, due 
to the adverse effect of tyrosine phosphorylation of α-actinin and 
increased levels of Ca2+ and PtdIns(3,4,5)-P3, actin cytoskeleton 
would not be able to effectively engage, allowing T-cell membrane 
relaxation, rapid redistribution of signaling membrane protein to 
the forming IS, and coalescence of various types of membrane 
LRs, including redistribution of Lck to light DRMs. Later, once 
the initial wave of secondary messengers wanes, actinin engages 
and bundles filamentous actin so that the formation and matura-
tion of actin architecture surrounding IS can be accomplished.
Taken together, data presented in this study advocate for the 
existence of a novel mechanism that integrates the engagement 
of TCR/CD4 receptors with cytoskeletal network via forming 
RACK1-based multiprotein network. While there is no doubt 
that more experimentation is necessary to fully elucidate its 
composition, structure, dynamics, kinetics, and the type of 
activation-dependent behavior, to the best of our knowledge, 
these are the first data that revealed its involvement in proximal 
T cell signaling with potential impact on the activation-induced 
repartitioning of Lck.
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ViDeO s1 | Time-lapse imaging racK1 redistribution into immunological 
synapse upon T-cell activation. WT Jurkat T-cells expressing RACK1-EGFP 
(green) constructs were mixed with SEE pulsed RAJI B-cells and the formation of 
IS was observed by live cell imaging microscopy.
ViDeO s2 | Time-lapse imaging of lck and racK1 co-redistribution into 
immunological synapse upon T-cell activation. Lck-deficient JCAM1.6 
Jurkat T-cells co-expressing Lck-CFP (red) and RACK1-mCitrine (green) 
constructs were mixed with SEE pulsed RAJI B-cells (blue) and the formation of 
IS was observed by live cell imaging microscopy.
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